跳至主要内容
临床试验/EUCTR2006-002603-13-NL
EUCTR2006-002603-13-NL进行中(未招募)1 期

Is treatment with octreotide effective in patients with head-and-neck paraganglioma? - octreotide in head and neck paraganglioma

eiden University Medical Center0 个研究点目标入组 30 人开始时间: 2006年5月12日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -presence of one or more paragangliomen/glomustumors in the head-and-neck area that grow fast (>/ 20%/year) and/or are complicated by cranial nerve palsy and/or production of catecholamines
  • -age 18-75 years
  • -positive octreotide scan
  • -informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -necessity for surgical intervention of the head-and-neck paraganglioma
  • -presence of additional paraganglioma in the thorax or abdomen
  • -presence of metastases of the head-and-neck paraganglioma
  • -cholelithiasis
  • -diabetes mellitus
  • -severe renal insufficiency (creatinine > 150 micromol/L), or liver failure(ALAT and/or ASAT >3x increased)

研究者

发起方
eiden University Medical Center

相似试验